Revenue Summary of Medistim ASA

Medistim ASA's latest annual revenue in 2023 was 521.1 Million NOK , up 8.25% from previous year.
Medistim ASA's latest quarterly revenue in 2024 Q3 was 132.75 Million NOK , down -8.39% from previous quarter.
Medistim ASA reported a annual revenue of 486.26 Million NOK in annual revenue 2022, up 16.38% from previous year.
Medistim ASA reported a annual revenue of 417.81 Million NOK in annual revenue 2021, up 17.3% from previous year.
Medistim ASA reported a quarterly revenue of 132.75 Million NOK for 2024 Q3, down -8.39% from previous quarter.
Medistim ASA reported a quarterly revenue of 133.78 Million NOK for 2024 Q1, down -1.35% from previous quarter.

Annual Revenue Chart of Medistim ASA (2023 - 2004)

Historical Annual Revenue of Medistim ASA (2023 - 2004)

Year	Revenue	Revenue Growth
2023	521.1 Million NOK	8.25%
2022	486.26 Million NOK	16.38%
2021	417.81 Million NOK	17.3%
2020	356.2 Million NOK	-0.2%
2019	356.91 Million NOK	10.5%
2018	323.01 Million NOK	9.11%
2017	296.05 Million NOK	12.71%
2016	262.67 Million NOK	5.08%
2015	249.97 Million NOK	16.67%
2014	214.25 Million NOK	12.57%
2013	190.33 Million NOK	4.59%
2012	181.97 Million NOK	14.01%
2011	159.61 Million NOK	1.8%
2010	156.8 Million NOK	-0.04%
2009	156.87 Million NOK	11.82%
2008	140.29 Million NOK	10.59%
2007	126.85 Million NOK	29.97%
2006	97.59 Million NOK	20.84%
2005	80.76 Million NOK	7.16%
2004	75.36 Million NOK	0.0%

Year	Revenue	Revenue Growth
2024 Q2	144.91 Million NOK	8.32%
2024 Q3	132.75 Million NOK	-8.39%
2024 Q1	133.78 Million NOK	-1.35%
2023 FY	526.36 Million NOK	8.25%
2023 Q3	124.09 Million NOK	-9.67%
2023 Q4	135.61 Million NOK	9.28%
2023 Q1	129.26 Million NOK	-5.06%
2023 Q2	137.38 Million NOK	6.29%
2022 Q1	116.12 Million NOK	12.44%
2022 Q3	116.49 Million NOK	-0.86%
2022 Q4	136.14 Million NOK	16.88%
2022 FY	486.26 Million NOK	16.38%
2022 Q2	117.49 Million NOK	1.18%
2021 Q4	103.28 Million NOK	1.12%
2021 FY	417.81 Million NOK	17.3%
2021 Q2	109.76 Million NOK	6.96%
2021 Q1	102.63 Million NOK	17.62%
2021 Q3	102.13 Million NOK	-6.95%
2020 FY	356.2 Million NOK	-0.2%
2020 Q1	103.1 Million NOK	16.03%
2020 Q2	82.48 Million NOK	-20.0%
2020 Q3	83.36 Million NOK	1.07%
2020 Q4	87.25 Million NOK	4.68%
2019 Q1	88.73 Million NOK	-6.64%
2019 Q2	93.79 Million NOK	5.7%
2019 FY	356.91 Million NOK	10.5%
2019 Q4	88.86 Million NOK	3.91%
2019 Q3	85.51 Million NOK	-8.83%
2018 Q4	95.04 Million NOK	22.46%
2018 Q2	76.22 Million NOK	2.82%
2018 Q1	74.13 Million NOK	-3.5%
2018 FY	323.01 Million NOK	9.11%
2018 Q3	77.61 Million NOK	1.83%
2017 Q4	76.82 Million NOK	1.49%
2017 Q2	69.17 Million NOK	-6.97%
2017 FY	296.05 Million NOK	12.71%
2017 Q3	75.69 Million NOK	9.42%
2017 Q1	74.36 Million NOK	19.85%
2016 Q1	65.5 Million NOK	-10.47%
2016 FY	262.67 Million NOK	5.08%
2016 Q4	62.04 Million NOK	-8.67%
2016 Q3	67.93 Million NOK	1.1%
2016 Q2	67.19 Million NOK	2.59%
2015 Q1	57.9 Million NOK	-11.63%
2015 FY	249.97 Million NOK	16.67%
2015 Q4	73.16 Million NOK	18.68%
2015 Q3	61.64 Million NOK	7.67%
2015 Q2	57.25 Million NOK	-1.13%
2014 FY	214.25 Million NOK	12.57%
2014 Q4	65.52 Million NOK	26.02%
2014 Q3	51.99 Million NOK	8.63%
2014 Q2	47.86 Million NOK	-2.02%
2014 Q1	48.85 Million NOK	-5.21%
2013 Q4	51.54 Million NOK	16.29%
2013 Q3	44.32 Million NOK	-9.48%
2013 FY	190.33 Million NOK	4.59%
2013 Q2	48.96 Million NOK	7.59%
2013 Q1	45.5 Million NOK	-5.1%
2012 Q2	43.94 Million NOK	-2.45%
2012 Q3	45.01 Million NOK	2.43%
2012 Q4	47.95 Million NOK	6.53%
2012 FY	181.97 Million NOK	14.01%
2012 Q1	45.05 Million NOK	14.96%
2011 Q4	39.19 Million NOK	7.98%
2011 FY	159.61 Million NOK	1.8%
2011 Q2	42.24 Million NOK	0.87%
2011 Q3	36.29 Million NOK	-14.09%
2011 Q1	41.88 Million NOK	-2.37%
2010 FY	156.8 Million NOK	-0.04%
2010 Q4	42.9 Million NOK	17.33%
2010 Q3	36.56 Million NOK	-9.47%
2010 Q2	40.38 Million NOK	9.29%
2010 Q1	36.95 Million NOK	-4.29%
2009 Q2	38.65 Million NOK	-3.58%
2009 Q1	40.08 Million NOK	0.0%
2009 FY	156.87 Million NOK	11.82%
2009 Q4	38.6 Million NOK	-2.31%
2009 Q3	39.52 Million NOK	2.24%
2008 FY	140.29 Million NOK	10.59%
2007 FY	126.85 Million NOK	29.97%
2006 FY	97.59 Million NOK	20.84%
2005 FY	80.76 Million NOK	7.16%
2004 FY	75.36 Million NOK	0.0%

Peer Revenue Comparison of Medistim ASA

Name	Revenue	Revenue Difference
Gentian Diagnostics ASA	136.19 Million NOK	-282.625%
Lifecare AS	13.08 Million NOK	-3882.135%

Global Stocks Search

Medistim ASA (MEDI.OL)

Revenue Summary of Medistim ASA

Annual Revenue Chart of Medistim ASA (2023 - 2004)

Historical Annual Revenue of Medistim ASA (2023 - 2004)

Peer Revenue Comparison of Medistim ASA